Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allopurinol dose-escalation versus fixed-dose allopurinol with or without colchicine for gout flare prevention
ChiCTR1900024963Phase 4Recruiting
- Sponsor
- Anqing City Hospital
- Start
- Jul 2019
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of allopurinol and colchicine in gout (3 arms), sponsored by Anqing City Hospital. Primary endpoint: Serum uric acid. Started Jul 2019; status: recruiting.
02
Drugs
allopurinolcolchicine
03
Conditions
gout
Beyond the preview
Go deeper on ChiCTR1900024963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900024963.